Preview

Russian Journal of Transplantology and Artificial Organs

Advanced search

COMPARISON OF THE EFFECTIVENESS OF METHODS FOR BONE MARROW HARVESTING FROM NON-HEART BEATING DONORS

https://doi.org/10.15825/1995-1191-2015-2-45-50

Abstract

Aim. To compare the effectiveness of different methods for bone marrow (BM) harvesting from non-heart beating donors taking into account the number and the quality of collected hematopoietic stem cells (HSC). Materials and methods. The study was performed on 43 non-heart beating donors. For BM harvesting two bone marrow aspiration needles were installed in each iliac bone. The needles were installed in one bone connected to closed system, combined with surgical suction and volumetric pump. BM aspiration was performed using different values for vacuum and combining with perfusion solution into the bone. The volume, the number of nucleated cells (NC), HSC and cell viability were evaluated in the obtained samples. Results. Compared with the standard mode the usage of vacuum 0.6–0.7 atm increased the collection of NC by 65.6%, HSC 87%, and did not reduce their viability. Using a vacuum of 0.9 atm reduced the amount of collected HSC and damaged cells. While using combined aspiration and perfusion of BM HSC were prepared at more than 86.2%, but the viability of the cells was lower than under the standard aspiration. Having coherently performed a standard aspiration and aspiration with perfusion from one iliac bone 407.2 ± 46.7 ml BM, 8.0 ± 0.8 × 109  NC and 194.2 ± 20.8 × 106  HSC were harvested. The proportion of viable cells was not less than 75.2 ± 3.2%. Conclusion. Method of BM harvesting implying coherently performing aspiration and aspiration-perfusion with the usage of vacuum 0.6–0.7 atm allows to prepare more progenitor cells without losing their quality. As a result, from one non-heart beating donor different types of progenitor cells can be collected in the amount sufficient for systemic infusion in adult patient.

About the Authors

M. Sh. Hubutija
N.V. Sklifosovsky Clinical and Research Institute for Emergency Medicine, Moscow
Russian Federation


I. N. Ponomarev
N.V. Sklifosovsky Clinical and Research Institute for Emergency Medicine, Moscow
Russian Federation

For correspondence: Ponomarev Ivan Nikolaevich. Address: 3/9, Bolshaya Sukharevskaya ploschad, Moscow, 129010, Russian Federation. Теl. (926) 281-12-40. E-mail: rzam@yandex.ru.

 



N. V. Borovkova
N.V. Sklifosovsky Clinical and Research Institute for Emergency Medicine, Moscow
Russian Federation


References

1. van Bekkum DW. Experimental basis of hematopoietic stem cell transplantation for treatment of autoimmune diseases. J Leukoc Biol. 2002; 72 (4): 609–620. Review. PubMed PMID: 12377928.

2. Nakao A, Toyokawa H, Kimizuka K, Nalesnik MA, Nozaki I, Bailey RJ et al. Simultaneous bone marrow and intestine transplantation promotes marrow-derived hematopoietic stem cell engraftment and chimerism. Blood. 2006; 108 (4): 1413–1420. DOI:10.1182/ blood-2006-02-004341.

3. Michalova J, Savvulidi F, Sefc L, Forgacova K, Necas E. Cadaveric bone marrow as potential source of hematopoietic stem cells for transplantation. Chimerism. 2011; 2 (3): 86–87. PubMed PMID: 22163067; PubMed CentralPMCID: PMC3234361.

4. Инструкция Министерства здравоохранения СССР по заготовке и консервированию посмертного костного мозга. М., 1989. Instruktsiya Ministerstva zdravookhraneniya SSSR рo zagotovke i konservirovaniyu posmertnogo kostnogo mozga. М., 1989.

5. Медведев ПМ, Раков АА, Пафомов ГА. Методы получения максимально возможного количества костного мозга и крови от трупов. Метод. рекомендации. Л.: НИИ гематологии и переливания крови, 1982: 25. Medvedev PM, Rakov AA, Pafomov GA. Metody polucheniya maksimal'no vozmozhnogo kolichestva kostnogo mozga i krovi ot trupov. Metod. rekomendatsii. L.: NII gematologii i perelivaniya krovi, 1982: 25.

6. Онищенко НА, Артамонов СД, Крашенинников МЕ, Башкина ЛВ, Никольская АО, Шагидулин МЮ и др. Клетки костного мозга донора как регулятор индукции иммунной толерантности в организме реципиента при аллогенной пересадке органов. Вестник трансплантологии и искусственных органов. 2009; XI (4): 97–102. Onishchenko NA, Artamonov SD, Krasheninnikov ME, Bashkina LV, Nikol’skaya AO, Shagidulin MY i dr. Donor’s bone marrow cells as regulator of immune tolerance induction in recipient’s of allogenic organs. Vestnik transplantologii i iskusstvennykh organov = Russian journal of transplantology and artificial organs. 2009; XI (4): 97–102. [English abstract].

7. Reinders ME, de Fijter JW, Roelofs H, Bajema IM, de Vries DK, Schaapherder AF et al. Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study. Stem Cells Transl Med. 2013; 2 (2): 107–111. DOI: 10.5966/sctm.2012-0114. PubMed PMID: 23349326; PubMed Central PMCID: PMC3659754.


Review

For citations:


Hubutija M.Sh., Ponomarev I.N., Borovkova N.V. COMPARISON OF THE EFFECTIVENESS OF METHODS FOR BONE MARROW HARVESTING FROM NON-HEART BEATING DONORS. Russian Journal of Transplantology and Artificial Organs. 2015;17(2):45-50. (In Russ.) https://doi.org/10.15825/1995-1191-2015-2-45-50

Views: 1484


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1995-1191 (Print)